Blood Cancers Today Associate Elias Jabbour, MD, gives an update from the 2023 European Hematology Association (EHA) Congress in Frankfurt, Germany.
2023 EHA Leukemia Update from Elias Jabbour, MD
By Leah Sherwood, Elias Jabbour, MD - Last Updated: February 8, 2024Post Tags:EHA2023
Related Posts
FDA shifts to real-time FAERS reporting, aiming to boost transparency in drug safety but raising concerns on data use.
Cardiovascular complications, such as those associated with arterial or venous thromboembolism, are a prominent concern.
Naval Daver, MD reviews new immunotherapy and targeted strategies transforming ALL treatment and outcomes.
The name change will take effect on August 28, ahead of Blood Cancer Awareness Month in September.
Guest contributor Moaath Mustafa Ali, MD, MPH, outlines the transforming treatment paradigm of Ph+ ALL.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.